| Ident. | Authors (with country if any) | Title |
|---|
| 000121 |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France] | Long-Term Outcomes of Surgical Therapies for Parkinson's Disease |
| 000165 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 000200 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000210 |
Laura Cif [France] ; Xavier Vasques [France] ; Victoria Gonzalez [France] ; Patrice Ravel [France] ; Brigitte Biolsi [France] ; Gwenaelle Collod-Beroud [France] ; Sylvie Tuffery-Giraud [France] ; Hassan Elfertit [France] ; Mireille Claustres [France] ; Philippe Coubes [France] | Long‐term follow‐up of DYT1 dystonia patients treated by deep brain stimulation: An open‐label study |
| 000253 |
Xavier Vasques [France] ; Laura Cif [France] ; Victoria Gonzalez [France] ; Claire Nicholson [France] ; Philippe Coubes [France] | Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation |
| 000298 |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study |
| 000308 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000314 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000318 |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 000322 |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease |
| 000328 |
Michael W. M. Schüpbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltête [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
| 000398 |
Djamel Ben Smail [France] ; Claire Jacq [France] ; Pierre Denys [France] ; Bernard Bussel [France] | Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia |
| 000424 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 000432 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 000444 |
Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne, France] ; Florian Kopper [Allemagne] ; Monika Pötter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] | Two‐year follow‐up of subthalamic deep brain stimulation in Parkinson's disease |
| 000445 |
Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
| 000447 |
Sylvie Raoul [France] ; Mirella Faighel [France] ; Isabelle Rivier [France] ; Marc Vérin [France] ; Youenn Lajat [France] ; Philippe Damier [France] | Staged lesions through implanted deep brain stimulating electrodes: A new surgical procedure for treating tremor or dyskinesias |
| 000455 |
Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
| 000459 |
Isabelle Benatru [France] ; Stéphane Thobois [France] ; Nathalie Andre-Obadia [France] ; Pierre-Marie Gonnaud [France] ; Yara Beaugendre [France] ; Colette Berger [France] ; Michel Gonce [Belgique] ; Emmanuel Broussolle [France] | Atypical propriospinal myoclonus with possible relationship to α interferon therapy |
| 000460 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Nadège Van Blercom [France] ; Jing Xie [France] ; Elena Moro [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease |
| 000464 |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
| 000466 |
Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis] | Surgery of the motor thalamus: Problems with the present nomenclatures |
| 000467 |
Laurent Vercueil [France] ; Paul Krack [France] ; Pierre Pollak [France] | Results of deep brain stimulation for dystonia: A critical reappraisal |
| 000468 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
| 000470 |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
| 000475 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 000477 |
Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France] | Mechanisms of deep brain stimulation |
| 000479 |
Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France] | Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats |
| 000480 |
Pierre Pollak [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Elena Moro [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France] | Intraoperative micro‐ and macrostimulation of the subthalamic nucleus in Parkinson's disease |
| 000491 |
Günther Deuschl [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [France] | Deep brain stimulation for movement disorders |
| 000499 |
Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France] | Fetal neural grafts for Huntington's disease: A prospective view |
| 000503 |
Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Féger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain |
| 000508 |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
| 000510 |
Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease |
| 000512 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 000531 |
David Devos [France] ; Luc Defebvre [France] ; Alain Destée [France] ; Jacques Caron [France] | Choreic movements induced by cibenzoline: An Ic class antiarrhythmic effect? |
| 000535 |
Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 000537 |
Alain Lagueny [France] ; François Tison [France] ; Pierre Burbaud [France] ; Gurendal Le Masson [France] ; Pascal Kien [France] | Stimulus‐sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A |
| 000538 |
Marion Simonetta Moreau [France] ; Alexandra Séverac Cauquil [France] ; Marie Claude Costes Salon [France] | Static and dynamic balance function in spasmodic torticollis |
| 000548 |
Gilles-Louis Defer [France] ; Hakan Widner [Suède] ; Rose-Marie Marié [France] ; Philippe Rémy [France] ; Marc Levivier [Belgique] | Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT‐PD) |
| 000550 |
Patrick Chariot [France] ; Pierre Brugières [France] ; Marie-Christine Eliezer-Vanerot [France] ; Christian Gény [France] ; Michel Binaghi [France] ; Pierre Césaro [France] | Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy |
| 000552 |
Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France] | A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
| 000554 |
Pierre Pollak [France] | Neurosurgical treatment of dyskinesias : Pathophysiological consideration |
| 000555 |
F. Le Doze [France] ; M. Moulin [France] ; G.-L. Defer [France] | Meige's syndrome in a patient treated with ranitidine |
| 000559 |
P. Krack [France] ; Abdelhamid Benazzouz [France] ; Pierre Pollak [France] ; Patricia Limousin [France] ; Brigitte Piallat [France] ; Dominique Hoffmann [France] ; Jing Xie [France] ; Alim-Louis Benabid [France] | Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation |
| 000573 |
James W. Lance [Australie] ; Ian Hickie [Brésil] ; Denis Wakefield [Australie] ; Colebatch [Australie] ; Francisco Cardoso [Brésil] ; Marie Vidailhet [France] | An akinetic‐rigid syndrome, depression, and stereotypies in a young man |
| 000574 |
A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study |
| 000575 |
Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study |
| 000577 |
J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; C. Geny [France] ; P. Cesaro [France] | Improvement of action tremor by chronic cortical stimulation |
| 000578 |
Olivier Rascol [France] ; K. Sieradzan [Royaume-Uni] ; H. Peyro-Saint-Paul [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; J. M. Senard [France] ; P. Ladure [France] ; J. L. Montastruc [France] ; A. Lees [Royaume-Uni] | Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy |
| 000579 |
B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France] | Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum |
| 000591 |
Nathalie Andreu [France] ; Christine Damase-Michel [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Montastruc [France] | A dose‐ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity |
| 000594 |
L. Derex [France] ; P. Trouillas [France] | Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy |
| 000602 |
Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France] | Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment |
| 000606 |
F. Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France] | Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease |
| 000607 |
P. Limousin [France] ; Pierre Pollak [France] ; D. Hoffmann [France] ; ABDELHAMID BENAZZOUZ [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France] | Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients |
| 000623 |
P. Limousin [France] ; Pierre Pollak [France] ; ABDELHAMID BENAZZOUZ [France] ; D. Hoffmann [France] ; E. Broussolle [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France] | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease |
| 000625 |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
| 000627 |
P. Krack [Allemagne] ; Marion [France] | “Apraxia of lid opening,” a focal eyelid dystonia: Clinical study of 32 patients |
| 000634 |
Olivier Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 000644 |
M. Vidailhet [France] ; C. Bouchard [France] ; P. J. Jedynak [France] ; M. Serdaru [France] | Acute and long‐term response to apomorphine in cranial dystonia |
| 000645 |
François Sellal [France] ; Edouard Hirsch [France] ; Pascal Barth [France] ; Serge Blond [France] ; Marescaux [France] | A case of symptomatic hemidystonia improved by ventroposterolateral thalamic electrostimulation |
| 000647 |
H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France] | Symptomatic effect of selegiline in De Novo Parkinsonian patients |
| 000649 |
A. Feve [France] ; B. Angelard [France] ; G. Fenelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-Guily | Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin |
| 000659 |
J.-F. De Saint Victor [France] ; C.-L. Gervason | Levopoda-induced diphasic dyskinesias improved by subcutaneous apomorphine |
| 000660 |
M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. Lataste | Effects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease |
| 000670 |
Emmanuelle Pourcher [France] ; Anne-Marie Bonnet [France] ; John Kefalos [France] ; Bruno Dubois [France] ; Agid [France] | Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's disease |
| 000672 |
J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse] | Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease |
